UnknownPhase 3NCT00376012

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tuberculosis Research Centre, India
Principal Investigator
Soumya Swaminathan, MD MNAMS
Tuberculosis Research Centre, India
Intervention
Anti-TB drugs (Ethambutol, Isoniazid, Rifampicin and Pyrazinamide)(drug)
Enrollment
300 enrolled
Eligibility
15-60 years · All sexes
Timeline
2001 – 2008

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00376012 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials